Cite
HARVARD Citation
Maruyama, D. et al. (2016). Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma. Cancer science. 107 (12), pp. 1785-1790. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maruyama, D. et al. (2016). Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma. Cancer science. 107 (12), pp. 1785-1790. [Online].